| http://dbpedia.org/ontology/abstract
|
Beam Therapeutics Inc. is an American biot … Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR and prime editing, whereby single nucleotides in a DNA sequence can be modified without cutting the DNA, theoretically reducing the likelihood of off-target effects compared to previous CRISPR-based methods.compared to previous CRISPR-based methods.
, Beam Therapeutics ist ein US-amerikanische … Beam Therapeutics ist ein US-amerikanisches Biotechnologieunternehmen, welches Forschung im Bereich Gentherapien und Genome Editing betreibt. Das Unternehmen hat seinen Hauptsitz in Cambridge im Bundesstaat Massachusetts. Bei der Entwicklung von Therapien setzt das Unternehmen auf das Base Editing, wobei DNA-Sequenzen noch genauer verändert werden können im Vergleich zu bisherigen Methoden.önnen im Vergleich zu bisherigen Methoden.
|
| http://dbpedia.org/ontology/foundingYear
|
2017
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Cambridge%2C_Massachusetts +
|
| http://dbpedia.org/ontology/numberOfEmployees
|
306
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://www.beamtx.com +
|
| http://dbpedia.org/ontology/wikiPageID
|
68190854
|
| http://dbpedia.org/ontology/wikiPageLength
|
4715
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1115677899
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Editas_Medicine +
, http://dbpedia.org/resource/Genome_editing +
, http://dbpedia.org/resource/Public_company +
, http://dbpedia.org/resource/CRISPR +
, http://dbpedia.org/resource/CRISPR_Therapeutics +
, http://dbpedia.org/resource/Category:2020_initial_public_offerings +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Pfizer +
, http://dbpedia.org/resource/Feng_Zhang +
, http://dbpedia.org/resource/Category:Health_care_companies_based_in_Massachusetts +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Gene_therapy +
, http://dbpedia.org/resource/Cambridge%2C_Massachusetts +
, http://dbpedia.org/resource/Massachusetts_Institute_of_Technology +
, http://dbpedia.org/resource/David_R._Liu +
, http://dbpedia.org/resource/Prime_editing +
, http://dbpedia.org/resource/Russell_2000 +
, http://dbpedia.org/resource/Category:American_companies_established_in_2017 +
, http://dbpedia.org/resource/Category:Gene_therapy +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Harvard_University +
, http://dbpedia.org/resource/IPO +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Broad_Institute +
, http://dbpedia.org/resource/Intellia_Therapeutics +
|
| http://dbpedia.org/property/bloomberg
|
BEAM:US
|
| http://dbpedia.org/property/date
|
March 2022
|
| http://dbpedia.org/property/google
|
BEAM
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/isin
|
US07373V1052
|
| http://dbpedia.org/property/location
|
Cambridge, Massachusetts, U.S.
|
| http://dbpedia.org/property/logoSize
|
200
|
| http://dbpedia.org/property/name
|
Beam Therapeutics Inc.
|
| http://dbpedia.org/property/numEmployees
|
306
|
| http://dbpedia.org/property/reason
|
What other methods?
|
| http://dbpedia.org/property/reuters
|
BEAM.O
|
| http://dbpedia.org/property/secCik
|
1745999
|
| http://dbpedia.org/property/symbol
|
BEAM
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Official +
, http://dbpedia.org/resource/Template:Ubl +
, http://dbpedia.org/resource/Template:Finance_links +
, http://dbpedia.org/resource/Template:Authority_control +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Start_date_and_age +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:URL +
, http://dbpedia.org/resource/Template:Vague +
, http://dbpedia.org/resource/Template:Reflist +
|
| http://dbpedia.org/property/yahoo
|
BEAM
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Companies_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Category:Gene_therapy +
, http://dbpedia.org/resource/Category:Health_care_companies_based_in_Massachusetts +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:American_companies_established_in_2017 +
, http://dbpedia.org/resource/Category:2020_initial_public_offerings +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Beam_Therapeutics?oldid=1115677899&ns=0 +
|
| http://xmlns.com/foaf/0.1/homepage
|
https://www.beamtx.com +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Beam_Therapeutics +
|
| http://xmlns.com/foaf/0.1/name
|
Beam Therapeutics Inc.
|
| owl:sameAs |
http://de.dbpedia.org/resource/Beam_Therapeutics +
, http://fa.dbpedia.org/resource/%D8%A8%DB%8C%D9%85_%D8%AA%D8%B1%D8%A7%D9%BE%DB%8C%D9%88%D8%AA%DB%8C%DA%A9%D8%B3 +
, https://global.dbpedia.org/id/FqGo2 +
, http://dbpedia.org/resource/Beam_Therapeutics +
, http://www.wikidata.org/entity/Q107457363 +
|
| rdf:type |
http://dbpedia.org/ontology/Company +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/ontology/Agent +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.wikidata.org/entity/Q43229 +
, http://schema.org/Organization +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://dbpedia.org/ontology/Organisation +
|
| rdfs:comment |
Beam Therapeutics ist ein US-amerikanische … Beam Therapeutics ist ein US-amerikanisches Biotechnologieunternehmen, welches Forschung im Bereich Gentherapien und Genome Editing betreibt. Das Unternehmen hat seinen Hauptsitz in Cambridge im Bundesstaat Massachusetts. Bei der Entwicklung von Therapien setzt das Unternehmen auf das Base Editing, wobei DNA-Sequenzen noch genauer verändert werden können im Vergleich zu bisherigen Methoden.önnen im Vergleich zu bisherigen Methoden.
, Beam Therapeutics Inc. is an American biot … Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR and prime editing, whereby single nucleotides in a DNA sequence can be modified without cutting the DNA, theoretically reducing the likelihood of off-target effects compared to previous CRISPR-based methods.compared to previous CRISPR-based methods.
|
| rdfs:label |
Beam Therapeutics
|
